Drug Side Effects
Search
CEREBRAL CAVERNOUS MALFORMATION
CEREBRAL CAVERNOUS MALFORMATION
was reported 45 times
CEREBRAL CAVERNOUS MALFORMATION is most prevalent among patients taking these drug classes:
#
Drug class
Count
Frequency
0
Thyroid Stimulating Hormone [EPC]
1
0.0010
1
Amyloid Beta-directed Antibody [EPC]
1
0.0003
2
Topoisomerase Inhibitor [EPC]
12
0.0002
3
Vasopressin V2 Receptor Antagonist [EPC]
1
0.0001
4
Anticholinergic [EPC]
1
0.0001
5
Carbonic Anhydrase Inhibitor [EPC]
1
0.0000
6
Alkylating Drug [EPC]
12
0.0000
7
Progesterone [EPC]
1
0.0000
8
Interleukin-6 Receptor Antagonist [EPC]
5
0.0000
9
Iron Chelator [EPC]
1
0.0000
10
Vascular Endothelial Growth Factor Inhibitor [EPC]
6
0.0000
11
Platinum-based Drug [EPC]
8
0.0000
12
Folate Analog Metabolic Inhibitor [EPC]
9
0.0000
13
Mood Stabilizer [EPC]
3
0.0000
14
Integrin Receptor Antagonist [EPC]
1
0.0000
15
Aminosalicylate [EPC]
1
0.0000
16
Interleukin-23 Antagonist [EPC]
1
0.0000
17
Progestin [EPC]
2
0.0000
18
Calcium [EPC]
1
0.0000
19
Janus Kinase Inhibitor [EPC]
1
0.0000
20
Thiazide Diuretic [EPC]
1
0.0000
21
Insulin Analog [EPC]
2
0.0000
22
Corticosteroid [EPC]
5
0.0000
23
Nucleoside Metabolic Inhibitor [EPC]
1
0.0000
24
Factor Xa Inhibitor [EPC]
1
0.0000
25
Kinase Inhibitor [EPC]
2
0.0000
26
Proton Pump Inhibitor [EPC]
2
0.0000
27
Vitamin D [EPC]
1
0.0000
28
Vitamin B12 [EPC]
1
0.0000
29
Dihydropyridine Calcium Channel Blocker [EPC]
1
0.0000
30
Vitamin C [EPC]
1
0.0000
31
Nonsteroidal Anti-inflammatory Drug [EPC]
2
0.0000